Analysis of Common Eligibility Criteria of Randomized Controlled Trials in Newly Diagnosed Multiple Myeloma Patients and Extrapolating Outcomes

This study provides insight into potential modifications of standard eligibility criteria that can lead to improved trial design.

Source: Clinical Lymphoma, Myeloma and Leukemia - June 16, 2017 Category: Hematology Authors: Jatin J. Shah, Rafat Abonour, Christina Gasparetto, James W. Hardin, Kathleen Toomey, Mohit Narang, Shankar Srinivasan, Amani Kitali, Faiza Zafar, E. Dawn Flick, Robert M. Rifkin Tags: Original Study Source Type: research